FDA urges stricter labeling on painkillers
The FDA will clamp down on the labeling of non-steroidal anti-inflammatory drugs (NSAIDS) in the coming months. According to its website, the FDA will require manufacturers of prescription NSAIDs and of over the counter NSAIDs to update their labels with more specific information about heart attack and stroke risks. In 2005, the FDA added a ...click here to read more






